Jeffrey W. Sherman, Director: Xeris Biopharma Holdings XERS Sell · Filed 25/08/29

Trade details

Type: Insider sale
Amount: $334,477.44
Shares · price: 42,232 sh · $7.92 a share
Held after: 219,188 sh
Stock: Xeris Biopharma Holdings XERS
Person: Jeffrey W. ShermanDirector
Trade date: 25/08/28
Filed: 25/08/29
Days to filing: 1 days

Sold 16.2% of holdings

Share of holding sold: 16.2%

Xeris Biopharma Holdings trades, last 26 weeks

What else happened in Xeris Biopharma Holdings around then

Filed or reported within 30 days of the trade day · 25/07/29~25/09/27

Jeffrey W. Sherman's recent trades

Jeffrey W. ShermanDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$25K
5,000 sh
$25K
Filed 03/02
Traded 02/27
Jeffrey W. ShermanDirector
Planned saleXeris Biopharma Holdings
Planned sale
Xeris Biopharma Holdings
XERS
$334.5K
42,232 sh
$334.5K
Filed 25/08/28
Traded 25/08/28
Jeffrey W. ShermanDirector
BuyXeris Biopharma Holdings
Buy
Xeris Biopharma Holdings
XERS
$10.1K
5,400 sh
$10.1K
Filed 23/11/29
Traded 23/11/27
Jeffrey W. ShermanEVP and Chief Medical Officer
SellHorizon Therapeutics Public
Sell
Horizon Therapeutics Public
HZNP
$380.8K
3,368 sh
$380.8K
Filed 23/01/12
Traded 23/01/10
Jeffrey W. ShermanEVP and Chief Medical Officer
SellHorizon Therapeutics Public
Sell
Horizon Therapeutics Public
HZNP
$380.9K
3,368 sh
$380.9K
Filed 23/01/12
Traded 23/01/11

Jeffrey W. Sherman, Director — sold $334.5K of Xeris Biopharma Holdings XERS · 16.2% of holdings | Whalegun